An advanced multifunctional prodrug combining photodynamic therapy with chemotherapy for highly efficient and precise tumor ablation
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Luminescence and Fluorescent Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (52)
Show source-provided references
1. Cancer statistics 2020
2. Cancer therapy: a move to the molecular level10.1039/a827251z ↗
3. A Multi-action and multi-target Ru(II) -Pt(IV) conjugate combining cancer-activated chemotherapy and photodynamic therapy to overcome drug resistant cancers10.1002/anie.201916400 ↗
4. The protide prodrug technology: from the concept to the clinic10.1021/acs.jmedchem.7b00734 ↗
5. Nanoplatform-based cascade engineering for cancer therapy10.1039/D0CS00607F ↗
6. Photoactivatable prodrug for simultaneous release of mertansine and CO along with a BODIPY derivative as a luminescent marker in mitochondria: a proof of concept for NIR image-guided cancer therapy10.1039/D0SC06270G ↗
7. Trojan Horse nanotheranostics with dual transformability and multifunctionality for highly effective cancer treatment10.1038/s41467-018-06093-5 ↗
8. In vivo and in situ tracking cancer chemotherapy by highly photostable NIR fluorescent theranostic prodrug10.1021/ja412380j ↗
9. An activatable prodrug for the treatment of metastatic tumors10.1021/ja5077684 ↗
10. Potent and prolonged innate immune activation by enzyme-responsive imidazoquinoline TLR7/8 agonist prodrug vesicles10.1021/jacs.0c01928 ↗
11. Reactive oxygen species (ROS)-based nanomedicine10.1021/acs.chemrev.8b00626 ↗
12. Imaging and photodynamic therapy: mechanisms, monitoring, and optimization10.1021/cr900300p ↗
13. Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy10.1039/C6CS00271D ↗
14. Recent progress in photosensitizers for overcoming the challenges of photodynamic therapy: from molecular design to application10.1039/D0CS00173B ↗
15. Inhibition of tumor growth and metastasis by photoimmunotherapy targeting tumor-associated macrophage in a sorafenib-resistant tumor model10.1016/j.biomaterials.2016.01.027 ↗
16. An integrin-targeting glutathione-activated zinc(II) phthalocyanine for dual targeted photodynamic therapy10.1016/j.ejmech.2019.04.049 ↗
17. Syntheses and photodynamic activity of some glucose-conjugated BODIPY dyes10.1016/j.ejmech.2016.06.050 ↗
18. Size-tunable targeting-triggered nanophotosensitizers based on self-assembly of a phthalocyanine-biotin conjugate for photodynamic therapy10.1021/acsami.9b13861 ↗
19. Preparation and in vitro photodynamic activities of folate-conjugated distyryl boron dipyrromethene based photosensitizers10.1021/jm4009168 ↗
20. A novel strategy for targeting photodynamic therapy. Molecular combo of photodynamic agent zinc(II) phthalocyanine and small molecule target-based anticancer drug erlotinib10.1039/c3cc45487h ↗
21. A molecular combo of zinc(II) phthalocyanine and tamoxifen derivative for dual targeting photodynamic therapy and hormone therapy10.1021/acs.jmedchem.7b00682 ↗
22. Controllable photodynamic therapy implemented by regulating singlet oxygen efficiency10.1002/advs.201700113 ↗
23. Activatable photosensitizers for imaging and therapy10.1021/cr900236h ↗
24. A glutathione-activated phthalocyanine-based photosensitizer for photodynamic therapy10.1002/chem.201400001 ↗
25. Near-IR absorbing BODIPY derivatives as glutathione-activated photosensitizers for selective photodynamic action10.1002/chem.201405450 ↗
26. A glutathione-responsive photosensitizer with fluorescence resonance energy transfer characteristics for imaging-guided targeting photodynamic therapy10.1016/j.ejmech.2020.112203 ↗
27. A glutathione-activatable photodynamic and fluorescent imaging monochromatic photosensitizer10.1039/C7TB00724H ↗
28. A hydrogen peroxide responsive resorufin-based phototheranostic agent for selective treatment of cancer cells10.1016/j.dyepig.2021.109499 ↗
29. Cytosolic NQO1 enzyme-activated nearinfrared fluorescence imaging and photodynamic therapy with polymeric vesicles10.1021/acsnano.9b08285 ↗
30. NIR photosensitizers activated by γ-glutamyl transpeptidase for precise tumor fluorescence imaging and photodynamic therapy10.1007/s11426-020-9947-4 ↗
31. Development of an azo-based photosensitizer activated under mild hypoxia for photodynamic therapy10.1021/jacs.7b05019 ↗
32. A nitroreductase-activatable near-infrared theranostic photosensitizer for photodynamic therapy under mild hypoxia10.1039/D0CC02019B ↗
33. pH-Activatable singlet oxygen-generating boron-dipyrromethenes (BODIPYs) for photodynamic therapy and bioimaging10.1021/acs.jmedchem.9b01873 ↗
34. Reactive oxygen species (ROS)-responsive prodrugs, probes, and theranostic prodrugs: applications in the ROS-related diseases10.1021/acs.jmedchem.0c01704 ↗
35. Reactive oxygen species-responsive nanoparticles based on PEGlated prodrug for targeted treatment of oral tongue squamous cell carcinoma by combining photodynamic therapy and chemotherapy10.1021/acsami.8b08269 ↗
36. Light-responsive prodrug-based supramolecular nanosystems for site-specific combination therapy of cancer10.1021/acs.chemmater.9b00439 ↗
37. NIR-Light-Activated combination therapy with a precise ratio of photosensitizer and prodrug using a host–guest strategy10.1002/anie.201900886 ↗
38. Light-triggered dual-modality drug release of self-assembled prodrug-nanoparticles for synergistic photodynamic and hypoxia-activated therapy10.1039/D0NH00034E ↗
39. ROS-responsive camptothecin prodrug nanoparticles for on-demand drug release and combination of chemotherapy and photodynamic therapy10.1002/adfm.202005918 ↗
40. Bioactivatable reactive oxygen species-sensitive nanoparticulate system for chemo-photodynamic therapy10.1016/j.actbio.2020.03.027 ↗
41. Time-programmed activation of dual polyprodrugs for synergistic cascade oxidation-chemotherapy10.1016/j.biomaterials.2021.121136 ↗
42. Multifunctional molecular therapeutic agent for targeted and controlled dual chemo- and photodynamic therapy10.1021/acs.jmedchem.0c00893 ↗
43. Far-red light-activatable prodrug of paclitaxel for the combined effects of photodynamic therapy and site-specific paclitaxel chemotherapy10.1021/acs.jmedchem.5b01971 ↗
44. Folate receptor-mediated enhanced and specific delivery of far-red light-activatable prodrugs of combretastatin A-4 to FR-positive tumor10.1021/bc500376j ↗
45. Visible light controlled release of anticancer drug through double activation of prodrug10.1021/ml3003617 ↗
46. Site-specific and far-red-light-activatable prodrug of combretastatin A-4 using photo-unclick chemistry10.1021/jm400139w ↗
47. A red light activatable multifunctional prodrug for image-guided photodynamic therapy and cascaded chemotherapy10.1002/adfm.201602541 ↗
48. Red light triggered photodynamic-chemo combination therapy using a prodrug caged by photosensitizer10.1016/j.ejmech.2021.113251 ↗
49. A camptothecin prodrug induces mitochondriamediated apoptosis in cancer cells with cascade activations10.1039/D1CC04379J ↗
50. The mechanism of topoisomerase I poisoning by a camptothecin analog10.1073/pnas.242259599 ↗
51. Application of multifunctional BODIPY in photodynamic therapy10.1016/j.dyepig.2020.108937 ↗
52. Photophysical and photochemical studies of zinc(II) phthalocyanine derivatives-effects of substituents and solvents10.1039/B315319C ↗